- Tytuł:
- Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma.
- Autorzy:
- Temat:
-
THERAPEUTIC use of monoclonal antibodies
PATIENT aftercare
IMMUNE checkpoint inhibitorsSKIN tumors
DESCRIPTIVE statistics
PROGRESSION-free survival
SQUAMOUS cell carcinoma
IMMUNOTHERAPY
OVERALL survival
DRUG toxicity - Źródło:
- Cancers; Jun2023, Vol. 15 Issue 12, p3180, 12p
Czasopismo naukowe